CM Life Sciences (CMLF) closed its initial public offering of 44.3M units at $10/unit; includes 5.78M units issued post underwriters exercising option in full.
Units listed on Nasdaq, commenced trading on September 2.
Each unit consists of one share of Class A common stock and one-third of one redeemable warrant; each whole warrant exercisable to purchase one share of Class A common stock at $11.50/share.
The company is formed for the purpose of effecting a business combination.
Intends to focus its search for business combination targets in life sciences industry segments, often fragmented, – life sciences tools, synthetic biology and diagnostics.
https://seekingalpha.com/news/3611830-cm-life-sciences-closes-442_8m-ipo
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.